\uff5e \u5927\u624b\u30b0\u30ed\u30fc\u30d0\u30eb\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u304c\u81e8\u5e8a\u8a66\u9a13\u306e\u52b9\u7387\u6539\u5584\u306e\u305f\u3081\u306b<\/p>\n
Vault Study Startup\u3068Vault eTMF\u3092\u63a1\u7528 \uff5e<\/p>\n
2020\u5e748\u670826\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n Bayer AG\u793e\u306e\u533b\u85ac\u54c1\u7814\u7a76\u958b\u767a\u8cac\u4efb\u8005\u3067\u3042\u308bJoerg Moeller\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c³Ô¹Ï±¬ÁÏ\u306e\u30af\u30e9\u30a6\u30c9\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3067\u3001\u5f53\u793e\u306f\u81e8\u5e8a\u8a66\u9a13\u306e\u5b9f\u65bd\u3092\u30b9\u30ea\u30e0\u5316\u3067\u304d\u308b\u3067\u3057\u3087\u3046\u3002³Ô¹Ï±¬ÁÏ\u306e\u6700\u5148\u7aef\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3068\u9867\u5ba2\u4e2d\u5fc3\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3078\u306e\u53d6\u308a\u7d44\u307f\u3092\u9ad8\u304f\u8a55\u4fa1\u3057\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n ³Ô¹Ï±¬ÁÏ\u306f\u3001Bayer AG\u793e\u304c\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u7d71\u5408\u3059\u308b\u305f\u3081\u306b\u3001\u8a66\u9a13\u306e\u30b3\u30f3\u30c6\u30f3\u30c4\u3084\u30c7\u30fc\u30bf\u3092\u5358\u4e00\u306e\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u4e0a\u3067\u7ba1\u7406\u3067\u304d\u308b\u3088\u3046\u652f\u63f4\u3057\u307e\u3059\u3002Vault Study Startup\u306f\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306e\u9078\u629c\u304b\u3089\u627f\u8a8d\u307e\u3067\u306e\u30a8\u30f3\u30c9\u30c4\u30fc\u30a8\u30f3\u30c9\u306e\u81e8\u5e8a\u8a66\u9a13\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u30d7\u30ed\u30bb\u30b9\u3092\u30b9\u30ea\u30e0\u5316\u3057\u307e\u3059\u3002Vault eTMF\u306f\u3001\u7a4d\u6975\u578b\u2018active\u2019TMF\u7ba1\u7406\u306b\u3088\u3063\u3066\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306e\u53ef\u8996\u6027\u3068\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u3092\u5b9f\u73fe\u3057\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u304c\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u9075\u5b88\u3057\u306a\u304c\u3089\u5e38\u306b\u67fb\u5bdf\u6e96\u5099\u4f53\u5236\u3092\u7dad\u6301\u3067\u304d\u308b\u3088\u3046\u306b\u3057\u307e\u3059\u3002<\/p>\n \u3053\u306e2\u3064\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u7d44\u307f\u5408\u308f\u305b\u308b\u3053\u3068\u3067\u3001Bayer AG\u793e\u306e\u81e8\u5e8a\u8a66\u9a13\u30c1\u30fc\u30e0\u306f\u624b\u4f5c\u696d\u306e\u30d7\u30ed\u30bb\u30b9\u3092\u524a\u6e1b\u3001\u540c\u3058\u8a66\u9a13\u6587\u66f8\u306e\u5171\u6709\u3001\u3055\u3089\u306b\u306fVault Study Startup\u304b\u3089Vault eTMF\u3078\u30b3\u30f3\u30c6\u30f3\u30c4\u3092\u81ea\u52d5\u30d5\u30a1\u30a4\u30ea\u30f3\u30b0\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ Development Cloud\u30b9\u30c8\u30e9\u30c6\u30b8\u30fc\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3067\u3042\u308bRik Van Mol\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3067\u306f\u3001\u5897\u3048\u7d9a\u3051\u308b\u81e8\u5e8a\u8a66\u9a13\u306b\u5bfe\u5fdc\u3059\u308b\u305f\u3081\u3001\u8a66\u9a13\u5b9f\u65bd\u306e\u8fc5\u901f\u5316\u306b\u5411\u3051\u3066³Ô¹Ï±¬ÁÏ Vault Clinical\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u63a1\u7528\u3059\u308b\u52d5\u304d\u304c\u5e83\u304c\u3063\u3066\u3044\u307e\u3059\u3002\u4eca\u5f8cBayer AG\u793e\u306f\u3001\u67fb\u5bdf\u6e96\u5099\u4f53\u5236\u3092\u5e38\u306b\u7dad\u6301\u3057\u305f\u72b6\u614b\u3067\u3001\u8a66\u9a13\u306e\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u304b\u3089\u5b8c\u4e86\u307e\u3067\u306e\u8a66\u9a13\u60c5\u5831\u3092\u5b8c\u5168\u306b\u53ef\u8996\u5316\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308b\u3067\u3057\u3087\u3046\u3002\u300d<\/p>\n Vault Study Startup\u3068Vault eTMF\u306f\u3001CDMS<\/a><\/strong>\u3001Study Startup<\/a><\/strong>\u3001eTMF<\/a><\/strong>\u3001CTMS<\/a><\/strong>\u3001\u304a\u3088\u3073Payments<\/a><\/strong>\u3092\u542b\u3080\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3068\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u7d71\u5408\u5316\u3059\u308b\u696d\u754c\u521d\u306e\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3042\u308b³Ô¹Ï±¬ÁÏ Vault Clinical Suite<\/a><\/strong>\u306e\u4e00\u90e8\u3067\u3059\u3002³Ô¹Ï±¬ÁÏ\u306e\u7d71\u5408\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u7fa4\u306f\u81e8\u5e8a\u8a66\u9a13\u696d\u52d9\u5168\u4f53\u3092\u53ef\u8996\u5316\u3057\u3001\u30a8\u30f3\u30c9\u30c4\u30fc\u30a8\u30f3\u30c9\u306e\u81e8\u5e8a\u8a66\u9a13\u30d7\u30ed\u30bb\u30b9\u3092\u30b9\u30ea\u30e0\u5316\u3057\u307e\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ Vault Clinical Suite\u306b\u3064\u3044\u3066\u306f\u30012020\u5e7410\u670813\uff5e14\u65e5\u306b\u958b\u50ac\u3055\u308c\u308b³Ô¹Ï±¬ÁÏ R&D and Quality Summit<\/a><\/strong>\u3067\u3082\u8a73\u3057\u304f\u53d6\u308a\u4e0a\u3052\u3089\u308c\u307e\u3059\u3002\u3053\u306e\u30d0\u30fc\u30c1\u30e3\u30eb\u30a4\u30d9\u30f3\u30c8\u306f\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u95a2\u4fc2\u8005\u9650\u5b9a\u306e\u30a4\u30d9\u30f3\u30c8\u3067\u3059\u3002\u53c2\u52a0\u767b\u9332\u304a\u3088\u3073\u6700\u65b0\u60c5\u5831\u306b\u3064\u3044\u3066\u306fveeva.com\/R&DSummit<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002\u307e\u305f\u3001veeva.com\/EUSummit<\/a><\/strong>\u306b\u3066³Ô¹Ï±¬ÁÏ R&D and Quality Summit, Europe\u3067\u516c\u958b\u3055\u308c\u305f\u30bb\u30c3\u30b7\u30e7\u30f3\u3092\u30aa\u30f3\u30c7\u30de\u30f3\u30c9\u3067\u3054\u8996\u8074\u3044\u305f\u3060\u3051\u307e\u3059\u3002<\/p>\n <\/p>\n \u3010<\/strong>³Ô¹Ï±¬ÁÏ Systems<\/strong>\u793e\u306b\u3064\u3044\u3066\u3011<\/strong> \u3010Forward-looking Statements\u3011 Bayer AG\u793eJoerg Moeller\u6c0f\uff1a³Ô¹Ï±¬ÁÏ\u306e\u30af\u30e9\u30a6\u30c9\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3067\u3001\u5f53\u793e\u306f\u81e8\u5e8a\u8a66\u9a13\u306e\u5b9f\u65bd\u3092\u30b9\u30ea\u30e0\u5316\u3067\u304d\u308b\u3067\u3057\u3087\u3046\u3002<\/p>\n","protected":false},"author":131,"featured_media":43980,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-43973","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43973"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=43973"}],"version-history":[{"count":4,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43973\/revisions"}],"predecessor-version":[{"id":44066,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43973\/revisions\/44066"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media\/43980"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=43973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=43973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=43973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ) \u306f\u3001Bayer AG\u793e\uff08ETR:BAYN\uff09\u304c\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306b\u304a\u3051\u308b\u8a66\u9a13\u306e\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3092\u52a0\u901f\u3057\u3001\u81e8\u5e8a\u8a66\u9a13\u5168\u4f53\u306e\u53ef\u8996\u6027\u3092\u5411\u4e0a\u3055\u305b\u308b\u305f\u3081\u3001³Ô¹Ï±¬ÁÏ Vault Study Startup<\/a><\/strong>\u3068³Ô¹Ï±¬ÁÏ Vault eTMF<\/a><\/strong>\u3092\u30b0\u30ed\u30fc\u30d0\u30eb\u3067\u63a1\u7528\u3057\u305f\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n
\n³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067\u3001875\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002
\n\u8a73\u3057\u304f\u306f\u3001https:\/\/veeva.com\/jp\/<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended April 30, 2020. This is available on the company\u2019s website at veeva.com under the Investors section and on the SEC\u2019s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"